BioRestorative Therapies Inc

NASDAQ BRTX

Data sourced from iex and EODHD
Download Data

BioRestorative Therapies Inc Cash Flow Statement 2009 - 2023

This table shows the Cash Flow Statement for BioRestorative Therapies Inc going from 2009 until 2023. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31 2013-12-31 2012-12-31 2011-12-31 2010-12-31 2009-12-31
Net Income
M -14 -18 -44 -11 -15 -13 -9 -9 -8 -6 -6 -7 -4 -2 -
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Non-Cash Items (Other)
M 8 0 1 5 5 3 1 1 0 0 0 2 0 1 -
Operating Cash Flow
M -6 -6 -3 -2 -7 -5 -4 -5 -3 -3 -3 -3 -3 -1 -
Capital Expenditures
M 0 0 0 0 0 0 0 0 0 0 0 -1 0 0 0
Net Acquisitions
M - - - - - - - - - - - - - - -
Other Investing Activities
M - - - - - - - - 0 0 - - - - -
Investing Cash Flow
M - - - - - - - - 0 0 - - - - -
Repayment/Issuance of Debt (Net)
M - - 0 4 6 4 2 1 1 1 - - - - -
Equity Repurchase (Common, Net)
M - - - 0 - - 2 4 2 3 - - 0 0 -
Dividends Paid
M 1 - - - - - - - - - - - - - -
Other Financial Activities
M 2 -13 1 1 11 5 4 2 2 1 2 2 3 0 -
Financing Cash Flow
M 2 -13 1 1 11 5 4 2 2 1 2 2 3 0 -
Exchange Rate Adjustment
M - - - - - - - - - - - - - - -
Beginning Cash
M 2 21 3 0 0 0 0 0 0 0 0 0 0 0 -
Ending Cash
M 1 2 21 3 0 0 0 0 0 0 0 0 0 0 0
Stock-Based Compensation
M 8 13 23 1 2 2 4 3 2 1 1 2 0 1 -
Issuance/Purchase of Shares
M - - - 0 - - 2 4 2 3 - - 0 0 -
Capital Stock Change
M 2 0 21 0 2 0 - - - - - - - - -
Working Capital
M 10 15 21 2 -14 -9 -8 -6 -5 -8 -7 -3 -4 -1 -
Free Cash Flow
M -7 -6 -3 -2 -7 -5 -4 -5 -4 -3 -3 -4 -3 -1 -

StockViz Staff

September 20, 2024

Any question? Send us an email